Continuous Central Venous Oxygen Saturation Assisted Intraoperative Hemodynamic Management

• Status: Completed
• Trial end date: 2013-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Patients who are scheduled for: elective oesophageal tumour resection, total gastrectomy, pancreas resection, major vascular, total cystectomy will be recruited.To investigate effects of central venous pressure (CVP) and central venous saturation (ScvO2) guided fluid management on intraoperative haemodynamic parameters, volume and vasopressor requirement, and postoperative organ function and postoperative inflammatory response.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Domonkos Trásy
• Treatments: Vasoconstrictor Agents

Criteria

Inclusion Criteria:

• patients undergoing the following elective major abdominal surgery: oesophagectomy, total gastrectomy, radical cystectomy, aorta-bifemoral bypass or elective operation of abdominal aortic aneurysm.

• after surgery patients were admitted to our intensive care unit.

Exclusion Criteria:

• patients younger than 18 years

• chronic organ insufficiency: "Acute Physiology and Chronic Health Evaluation (APACHE) II" scoring system: New York Heart Association Class IV, chronic hypoxia or hypercapnia, chronic renal failure requiring renal replacement therapy, biopsy proven cirrhosis or portal hypertension and immunodeficiency.

• preoperative anaemia (haemoglobin<100g/L)

• coagulation abnormality

• and patients with chronic use of corticosteroids and non-steroid anti-inflammatory drugs

• patients requiring an operation due to malignant disease where the tumour then proved to be inoperable.